Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)

NCT01476085 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated as ongoing analysis suggested objectives not practical to achieve with study as implemented

Conditions

Interventions

Sponsor

GlaxoSmithKline